真性红细胞增多症的病理生理学及病程与治疗的关系 - Suppr

Suppr

超能文献

Physiopathology and course of polycythemia vera as related to therapy.

作者信息

DAMESHEK W

出版信息

J Am Med Assoc. 1950 Mar 18;142(11):790-7. doi: 10.1001/jama.1950.02910290018005.

DOI:10.1001/jama.1950.02910290018005

PMID:15405984

Abstract

摘要

相似文献

Physiopathology and course of polycythemia vera as related to therapy.

J Am Med Assoc. 1950 Mar 18;142(11):790-7. doi: 10.1001/jama.1950.02910290018005.

Familial polycythemia vera with Budd-Chiari syndrome in childhood.

Br J Haematol. 2003 Oct;123(2):346-52. doi: 10.1046/j.1365-2141.2003.04591.x.

[Polycythemia vera; course and prognosis].

Ugeskr Laeger. 1950 Jun 1;112(22):795-9.

[Physiopathology and treatment of polycythemia vera].

Nihon Naika Gakkai Zasshi. 2007 Jul 10;96(7):1382-9. doi: 10.2169/naika.96.1382.

No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials.

Haematologica. 2017 Jun;102(6):e219-e221. doi: 10.3324/haematol.2017.165126. Epub 2017 Mar 2.

Hyperlipidemia and myocardial infarction among 118 patients with polycythemia vera.

Am J Med Sci. 1978 Jul-Aug;276(1):23-6. doi: 10.1097/00000441-197807000-00002.

[Studies on polycythemia with special reference to polycythemia vera].

Dia Med. 1952 Oct 27;24(72):1894.

[Course and outcome of polycythemia].

Klin Med (Mosk). 1951 Oct;29(10):67-72.

[Association of polycythemia vera and multiple myeloma. Presentation ofa new case and review of the literature].

Sangre (Barc). 1993 Dec;38(6):497-9.

[A case of dilated cardiomyopathy caused by myocardial microinfarcts in the course of polycythemia vera].

Pol Merkur Lekarski. 1998 Jan;4(19):26-8.

引用本文的文献

JAK2 V617F allele burden in polycythemia vera: burden of proof.

Blood. 2023 Apr 20;141(16):1934-1942. doi: 10.1182/blood.2022017697.

2016 WHO Clinical Molecular and Pathological Criteria for Classification and Staging of Myeloproliferative Neoplasms (MPN) Caused by MPN Driver Mutations in the JAK2, MPL and CALR Genes in the Context of New 2016 WHO Classification: Prognostic and Therapeutic Implications.

Maedica (Bucur). 2016 Mar;11(1):5-25.

Thrombopoietin and its receptor in normal and neoplastic hematopoiesis.

Thromb J. 2016 Oct 4;14(Suppl 1):40. doi: 10.1186/s12959-016-0095-z. eCollection 2016.

Physiopathology, etiologic factors, diagnosis, and course of polycythemia vera as related to therapy according to william dameshek, 1940-1950.

Turk J Haematol. 2013 Jun;30(2):102-10. doi: 10.4274/Tjh.2013.0029. Epub 2013 Jun 5.

Myelosclerosis.

Br Med J. 1956 Oct 20;2(4998):927-9.

The Survival of Transfused Erythrocytes from Patients with Polycythaemia Vera.

J Clin Pathol. 1951 May;4(2):218-20. doi: 10.1136/jcp.4.2.218.

[Radiotherapy with radiophosphorus in polycythemia rubra vera].

Klin Wochenschr. 1952 Jan 1;30(1-2):28-30. doi: 10.1007/BF01478756.

Oral treatment of polycythaemia vera with beta-naphthyl-di-2-chloroethylamine (R48).

Br Med J. 1951 Sep 1;2(4730):510-3. doi: 10.1136/bmj.2.4730.510.

[Treatment of polycythemia vera with daraprim].

Klin Wochenschr. 1956 May 15;34(19-20):512-6. doi: 10.1007/BF01476073.

Polycythemia vera: its course and treatment; relation to myeloid metaplasia and leukemia.

Bull N Y Acad Med. 1954 May;30(5):343-75.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验